Antiplatelet Therapy Not Yet Recruiting Phase 4 Trials for Ticagrelor (DB08816)

Also known as: Anti-platelet Therapy

IndicationStatusPhase
DBCOND0047920 (Antiplatelet Therapy)Not Yet Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04060914LOwer Maintenance Dose TICagrelor in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary InterventionTreatment